Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 4Phase 1/2 3Phase NA 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 10NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Breast Neoplasms, Male 1

Interventions

Radiotherapy 17Magnetic Resonance Spectroscopy 16Psychiatric Rehabilitation 13Cyclophosphamide 13Early Intervention, Educational 11Methotrexate 9Doxorubicin 9Counseling 9Biopsy 9Vincristine 8Cytarabine 7Carboplatin 7Specimen Handling 6Neoadjuvant Therapy 6Immunohistochemistry 6Gene Expression Profiling 6Dexamethasone 6Chemotherapy, Adjuvant 6Prednisolone 5Peripheral Blood Stem Cell Transplantation 5Leucovorin 5Immunoenzyme Techniques 5High-Energy Shock Waves 5Fluorouracil 5Filgrastim 5Colposcopy 5Cisplatin 5Busulfan 5X-Rays 4Polymerase Chain Reaction 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × NIH × Flow Cytometry × Clear all
NCT00436709 2014-01-06

Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer

National Cancer Institute (NCI)

Phase NA Unknown
75 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00689975 2013-08-26

Diet and Exercise or Normal Care in Overweight or Obese Women Who Have Undergone Treatment for Stage I, Stage II, or Stage III Breast Cancer

National Cancer Institute (NCI)

Phase NA Completed
100 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡